Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.41 | 0.2 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |